The roles of 3' and 4' hydroxy groups in alpha-galactosylceramide stimulation of invariant natural killer T cells (Q36452784)

14 August 2017

The roles of 3' and 4' hydroxy groups in alpha-galactosylceramide stimulation of invariant natural killer T cells (English)

1 reference

14 August 2017

Robert Burns Woodward

7

object named as

Robert Woodward

1 reference

14 August 2017

10

Mitchell Kronenberg

1 reference

14 August 2017

Chengfeng Xia

1

1 reference

14 August 2017

Wenpeng Zhang

2

1 reference

14 August 2017

Yalong Zhang

3

1 reference

14 August 2017

Wenlan Chen

4

1 reference

14 August 2017

Janos Nadas

5

1 reference

14 August 2017

Ryan Severin

6

1 reference

14 August 2017

Bin Wang

8

1 reference

14 August 2017

Xin Wang

9

1 reference

14 August 2017

Peng G Wang

11

1 reference

14 August 2017

1 November 2009

1 reference

14 August 2017

1 reference

14 August 2017

4

1 reference

14 August 2017

11

1 reference

14 August 2017

1810-1815

1 reference

Alpha-lactosylceramide as a novel "sugar-capped" CD1d ligand for natural killer T cells: biased cytokine profile and therapeutic activities

14 August 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3517047

A minimal binding footprint on CD1d-glycolipid is a basis for selection of the unique human NKT TCR.

30 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3517047

CD1d-lipid-antigen recognition by the semi-invariant NKT T-cell receptor

30 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3517047

Mechanistic studies and methods to prevent aglycon transfer of thioglycosides

30 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3517047

Natural killer T cells recognize diacylglycerol antigens from pathogenic bacteria

30 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3517047

Design of natural killer T cell activators: structure and function of a microbial glycosphingolipid bound to mouse CD1d

30 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3517047

iNKT-cell responses to glycolipids

30 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3517047

Structure and function of a potent agonist for the semi-invariant natural killer T cell receptor

30 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3517047

Toward an understanding of NKT cell biology: progress and paradoxes

30 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3517047

Bacterial glycolipids and analogs as antigens for CD1d-restricted NKT cells

30 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3517047

A reversible defect in natural killer T cell function characterizes the progression of premalignant to malignant multiple myeloma

30 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3517047

Activation of CD1d-restricted T cells protects NOD mice from developing diabetes by regulating dendritic cell subsets

30 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3517047

Glycolipid antigen processing for presentation by CD1d molecules.

30 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3517047

Natural killer T cell activation inhibits hepatitis B virus replication in vivo.

30 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3517047

CD1d-restricted recognition of synthetic glycolipid antigens by human natural killer T cells

30 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3517047

Selective ability of mouse CD1 to present glycolipids: alpha-galactosylceramide specifically stimulates V alpha 14+ NK T lymphocytes.

30 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3517047

Mouse CD1-autoreactive T cells have diverse patterns of reactivity to CD1+ targets

30 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3517047

CD1d-restricted and TCR-mediated activation of valpha14 NKT cells by glycosylceramides

30 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3517047

The crystal structure of human CD1d with and without alpha-galactosylceramide

30 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3517047

Mouse CD1-specific NK1 T cells: development, specificity, and function

28 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3517047

Loss of IFN-gamma production by invariant NK T cells in advanced cancer.

28 June 2018

1 reference

Crossref

https://api.crossref.org/works/10.1002%2FCMDC.200900350

The V alpha 14 NKT cell TCR exhibits high-affinity binding to a glycolipid/CD1d complex.

21 January 2018

1 reference

Crossref

https://api.crossref.org/works/10.1002%2FCMDC.200900350

Synthesis and preliminary antifungal evaluation of a library of phytosphingolipid analogues

21 January 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3517047

Glycodiversification for the optimization of the kanamycin class aminoglycosides

21 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3517047

Recognition of bacterial glycosphingolipids by natural killer T cells

21 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3517047

Synthesis of uridine 5'-[2-S-pyridyl-3-thio-alpha-D-galactopyranosyl diphosphate]: precursor of UDP-thiogal sugar nucleotide donor substrate for beta-1,4-galactosyltransferase

21 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3517047

Synthesis and NKT cell stimulating properties of fluorophore- and biotin-appended 6"-amino-6"-deoxy-galactosylceramides

21 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3517047

A synthetic glycolipid prevents autoimmune encephalomyelitis by inducing TH2 bias of natural killer T cells

21 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3517047

Conserved and Heterogeneous Lipid Antigen Specificities of CD1d-Restricted NKT Cell Receptors

21 September 2018

1 reference

12 December 2020

The natural killer T-cell ligand α-galactosylceramide prevents autoimmune diabetes in non-obese diabetic mice

1 reference

12 December 2020

CD1d-dependent macrophage-mediated clearance of Pseudomonas aeruginosa from lung

1 reference

12 December 2020

The C-Glycoside Analogue of the Immunostimulantα-Galactosylceramide (KRN7000): Synthesis and Striking Enhancement of Activity

1 reference

12 December 2020

Structure-activity relationship of alpha-galactosylceramides against B16-bearing mice

1 reference

12 December 2020

KRN7000, a novel immunomodulator, and its antitumor activities

1 reference

12 December 2020

Activated NKT cells inhibit autoimmune diabetes through tolerogenic recruitment of dendritic cells to pancreatic lymph nodes

1 reference

12 December 2020

Antitumor effect of alpha-galactosylceramide (KRN7000) on spontaneous hepatic metastases requires endogenous interleukin 12 in the liver

1 reference

12 December 2020

Antitumor activity of alpha-galactosylceramide, KRN7000, in mice with the melanoma B16 hepatic metastasis and immunohistological study of tumor infiltrating cells

1 reference

12 December 2020

Improved outcomes in NOD mice treated with a novel Th2 cytokine-biasing NKT cell activator

1 reference

12 December 2020

NKT cells are critical to initiate an inflammatory response after Pseudomonas aeruginosa ocular infection in susceptible mice

1 reference

12 December 2020

Agelasphins, novel α-galactosylceramides from the marine sponge Agelas mauritianus

1 reference

Crossref

https://api.crossref.org/works/10.1002%2FCMDC.200900350

7 January 2021

inferred from DOI database lookup

Identifiers

DOI

10.1002/CMDC.200900350

1 reference

14 August 2017

1 reference

14 August 2017

PubMed publication ID

19780098

1 reference